ABC-1183

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameABC-1183
Drug Alias NameABC-1183
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 inhibitors +[2] 
TargetsCyclin-dependent kinase 9Glycogen synthase kinase-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApogee Biotechnology Co
China Registration ClassN/A

Develop Information

Active CompaniesApogee Biotechnology Co
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A